In this episode of Derms and Conditions, our host, James Q. Del Rosso, DO, interviews April Armstrong, MD, MPH, a professor and Chief of Dermatology at UCLA, about the development of tapinarof, a novel nonsteroidal topical treatment for psoriasis.
They begin by discussing Dr Armstrong’s history of professional interest in psoriasis. The conversation then moves to focus solely on tapinarof, a topical cream that works by modulating the aryl hydrocarbon receptor (AhR).
Dr Armstrong explains the unique mechanism of action of tapinarof and its effects on Th17 cytokines, antioxidant activity, and skin barrier function. She also discusses the efficacy demonstrated in clinical trials, with nearly 40% of patients achieving PASI 75 after 12 weeks, as well as the remittive effect in maintaining clear or almost clear skin.
They address the safety profile of tapinarof, including the occurrence of folliculitis and contact irritation, and provide tips for its use in clinical practice. Dr Armstrong also emphasizes its versatility and potential as a combination therapy with systemic medications. All in all, the episode provides listeners with an expansive understanding of tapinarof as an effective and well-tolerated nonsteroidal treatment for plaque psoriasis.
Improving Your Clinical Approach To Chronic Urticaria
Outside the Box: The Power of Combining Art and Science
Comprehensive Management of Hidradenitis Suppurativa: Expert Insights From Dr Jennifer Hsiao
Part 2: Special Edition on Recent Reports of Benzene Found in Benzoyl Peroxide Products
Part 1: Special Edition on Recent Reports of Benzene Found in Benzoyl Peroxide Products
Prescribed Success: Navigating Buy-and-Bill Strategies in Dermatology Practice
Highlights of Winter Clinical Miami 2024
Highlights of Winter Clinical Hawaii 2024
A Deep Dive Into IL-17 Inhibition and Bimekizumab for Psoriasis: Straight Talk with Dr Andy Blauvelt
Final Thoughts from 2023: Highlights from Podcasts Past…
Untangling the Questions and Challenges in Patients with Hair Loss: Part 2
Untangling the Questions and Challenges in Patients with Hair Loss: Part 1
Does Bimekizumab Raise the Bar of Success for Moderate-to-Severe Plaque Psoriasis? Perspectives from Dr. Ted Rosen
Beyond the Knife: Practical Nonsurgical Options for Skin Cancer
What is Dr Adam Friedman Up To Now?
Live From Las Vegas! Greatest Hits from Fall Clinical Dermatology 2023
Once Is Not Enough: Round 2 on Therapeutic Insights
A Closer Look at How to Address Skin Care With Your Patients
Improving Our Understanding of How Drugs Work: Clarifying Questions with Monoclonal Antibodies and JAK Inhibitors.
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive